Taken together, these data suggest that ZBTB18 exerts a repressive action on the expression and consequent release of cytokines that might play a relevant role in shaping the tumor microenvironment and ultimately, influence the patients’ clinical outcome. The gene discussed is ZBTB18; the disease is neoplasm.